# INSIGHT: A Phase III Trial of Ripretinib Versus Sunitinib in Patients with Advanced GIST with KIT Exon 11 and Exon 17/18 Mutations Who Were Previously Treated with Imatinib

**Authors:** Carolina Larrain, Tracey Pu, Paulina Cox, Kam Sprott, Andrew M. Blakely, Sebastian Bauer, Suzanne George

PMC · DOI: 10.1245/s10434-024-16853-x · 2025-02-05

## Full-text entities

- **Genes:** KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}
- **Diseases:** GIST (MESH:D046152)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11976832/full.md

---
Source: https://tomesphere.com/paper/PMC11976832